
Reset all filters
01 2GILEAD SCIENCES INC
Reset all filters
01 210385067
Reset all filters
01 2Blank
Reset all filters
01 2Blank
Reset all filters
01 22035-06-19
Patent Expiration Date : 2035-06-19
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 10385067
Drug Substance Claim :
Drug Product Claim :
Application Number : 210251
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2035-06-19
Patent Expiration Date : 2035-06-19
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 10385067
Drug Substance Claim :
Drug Product Claim :
Application Number : 210251
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2035-06-19